EUCTR2014-001856-51-DK进行中（未招募）1 期
Anti-fibrotic and molecular aspects of rifaximin in alcoholic liver disease: A randomized placebo controlled clinical trial
Aleksander Krag0 个研究点目标入组 136 人开始时间: 2014年6月10日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 136
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Liver fibrosis estimated by an Ishak score from 1-4
- •2. Women of child-bearing potential should use safe anti-conception and provide a negative pregnancy test.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 120
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 16
排除标准
- •1. Known allergy to rifaximin
- •2. The investigator judge that the patient would not be compliant with trial medicine
- •3. Antibiotic treatment the prior 4 weeks
研究者
相似试验
已完成
3 期
The effect of rifaximin in different doses on symptoms and quality of life improvement in Iranian patients with diarrhea-predominant irritable bowel syndromeIrritable bowel syndrome with diarrheaIRCT20141201020178N11Iran University of Medical Sciences200
进行中（未招募）
不适用
Effects of rifaximin administration in patients with severe acute alcoholic hepatitis. Comparative pilot study.EUCTR2012-000515-80-ESJuan Córdoba
进行中（未招募）
1 期
Effect of administration of Rifaximin on the increased portal pressure of patients with liver cirrhosis and esophageal varices already treated with propranololEUCTR2014-000102-35-ITClinica Medica 560
招募中
3 期
The effect of rifaximin in IBSIrritable bowel syndrome.Irritable bowel syndromeIRCT20221211056775N1Arak University of Medical Sciences60
尚未招募
2 期
Role of a type of amino acid in confusion related to liver diseasesCTRI/2019/08/020552Pavan kumar KV